Mosquito-Borne Rift Valley Fever Virus Linked to Miscarriage in Humans
|
By LabMedica International staff writers Posted on 11 Oct 2016 |

Image: Proteins from Rift Valley fever virus (Photo courtesy of Medical Xpress).
Rift Valley fever virus (RVFv) has been linked to miscarriage in a cross-sectional study of pregnant Sudanese women with fever, which indicated a 7 times greater risk of miscarriage for infected women.
“In parts of Africa where there are RVF outbreaks, human miscarriages have never been linked to this particular viral infection, until now,” said co-author Magnus Evander, professor at Umeå University Faculty of Medicine (Umeå, Sweden), “With these results, we can add miscarriage to the list of known complications from RVF. This discovery is important for maternal health and for our efforts to develop preventive measures to minimize miscarriages, which are a big health problem for women in the affected areas of Africa.” The study was a collaboration between researchers at Umeå University, the Swedish Defense Research Agency (FOI), and clinicians in Sudan.
RVFv, mostly in Africa and on the Arabian Peninsula, regularly causes large outbreaks with hundreds of thousands of infected people and animals (e.g. cows, sheep, goats). RVF usually produces mild, influenza-like symptoms in humans, but in about 8% of cases, infected people develop serious symptoms, such as liver damage, serious eye infection, internal and external bleeding, meningitis, and death. In animals it often leads to death and as well as pregnancy miscarriages.
The new results are based on a study of 130 pregnant women with fever in Sudan, where outbreaks are a large and recurring health problem. Of the 130 patients, 27 had a miscarriage and 4 had premature births. The women infected with RVFv had a 7 times greater risk of miscarriage.
”Because RVF is caused by a mosquito-borne virus, there is a potential risk of global spread, which has been the case with the Zika virus. The fact that RVF could lead to miscarriage is very worrying,” said Prof. Evander.
The study was published September 27, 2016, in the journal Lancet Global Health.
Related Links:
Umeå University Faculty of Medicine
“In parts of Africa where there are RVF outbreaks, human miscarriages have never been linked to this particular viral infection, until now,” said co-author Magnus Evander, professor at Umeå University Faculty of Medicine (Umeå, Sweden), “With these results, we can add miscarriage to the list of known complications from RVF. This discovery is important for maternal health and for our efforts to develop preventive measures to minimize miscarriages, which are a big health problem for women in the affected areas of Africa.” The study was a collaboration between researchers at Umeå University, the Swedish Defense Research Agency (FOI), and clinicians in Sudan.
RVFv, mostly in Africa and on the Arabian Peninsula, regularly causes large outbreaks with hundreds of thousands of infected people and animals (e.g. cows, sheep, goats). RVF usually produces mild, influenza-like symptoms in humans, but in about 8% of cases, infected people develop serious symptoms, such as liver damage, serious eye infection, internal and external bleeding, meningitis, and death. In animals it often leads to death and as well as pregnancy miscarriages.
The new results are based on a study of 130 pregnant women with fever in Sudan, where outbreaks are a large and recurring health problem. Of the 130 patients, 27 had a miscarriage and 4 had premature births. The women infected with RVFv had a 7 times greater risk of miscarriage.
”Because RVF is caused by a mosquito-borne virus, there is a potential risk of global spread, which has been the case with the Zika virus. The fact that RVF could lead to miscarriage is very worrying,” said Prof. Evander.
The study was published September 27, 2016, in the journal Lancet Global Health.
Related Links:
Umeå University Faculty of Medicine
Latest Microbiology News
- RNA-Based Workflow Identifies Active Skin Microbes for Dermatology Research
- Cost-Effective Sampling and Sequencing Workflow Identifies ICU Infection Hotspots
- New Bacterial Target Identified for Early Detection of Noma
- Genomic Analysis Links Emerging Streptococcal Strains to Specific Infections
- Rapid Urine Test Speeds Antibiotic Selection for UTIs
- WHO Endorses Rapid Point-of-Care Testing to Improve TB Detection
- Breath Analysis Approach Offers Rapid Detection of Bacterial Infection
- Study Highlights Accuracy Gaps in Consumer Gut Microbiome Kits
- WHO Recommends Near POC Tests, Tongue Swabs and Sputum Pooling for TB Diagnosis
- New Imaging Approach Could Help Predict Dangerous Gut Infection
- Rapid Sequencing Could Transform Tuberculosis Care
- Blood-Based Viral Signature Identified in Crohn’s Disease
- Hidden Gut Viruses Linked to Colorectal Cancer Risk
- Three-Test Panel Launched for Detection of Liver Fluke Infections
- Rapid Test Promises Faster Answers for Drug-Resistant Infections
- CRISPR-Based Technology Neutralizes Antibiotic-Resistant Bacteria
Channels
Clinical Chemistry
view channel
Study Finds ApoB Testing More Effective Than LDL for Guiding Lipid Therapy
Routine blood tests that measure low-density lipoprotein (LDL), commonly known as “bad” cholesterol, are widely used to guide lipid-lowering therapy, but they do not always provide a complete picture of... Read more
AI-Enabled POC Test Quantifies Multiple Cardiac Biomarkers
Cardiovascular diseases are a leading cause of death, responsible for nearly 20 million deaths each year. Timely triage of myocardial infarction and heart failure hinges on rapid cardiac biomarker measurement,... Read moreNext Generation Automated Analyzers Increase Throughput for Clinical Chemistry and Electrolyte Testing
Clinical laboratories continue to face staffing shortages, limited space, and growing test volumes that pressure chemistry and electrolyte workflows. Maintaining rapid turnaround times increasingly depends... Read moreMolecular Diagnostics
view channel
Urine-Based Assay Predicts Severe Dengue Risk Early
Dengue is among the most widespread mosquito-borne infections, yet early risk stratification can be difficult when symptoms overlap with other febrile illnesses. Only about 2% to 5% of patients develop... Read more
CE-Marked Blood Test Enables Monitoring of Neuroinflammation in Multiple Sclerosis
Multiple sclerosis affects more than 2.9 million people worldwide and requires ongoing evaluation of disease activity to guide care. Routine monitoring often depends on magnetic resonance imaging (MRI),... Read more
Ultrasensitive Assay Tracks Resistance Mutations MRD Monitoring
Ultrasensitive circulating tumor DNA assessment is being applied to predict and track response to immunotherapy and to detect relapse across multiple solid tumors. Monitoring resistance mutations such... Read more
Extracellular Vesicle RNA Biomarkers Enable Noninvasive IBD Diagnosis and Monitoring
Inflammatory bowel disease (IBD) is a chronic, relapsing gastrointestinal condition whose incidence is rising in industrialized and newly industrialized countries, with prevalence in early‑industrialized... Read moreHematology
view channel
Routine Blood Test Parameters Link Anemia to Cancer Risk and Mortality
Anemia detected in routine care can signal underlying pathology and is frequently encountered in adults. Because it is defined by hemoglobin levels below the normal range, it is often evaluated with red... Read more
Prognostic Tool Guides Personalized Treatment in Rare Blood Cancer
Chronic myelomonocytic leukemia (CMML) is a rare blood cancer in which acquired genetic mutations in bone marrow stem cells drive disease. Stem cell transplantation is the only curative option but carries... Read moreImmunology
view channel
Study Finds Influenza Often Undiagnosed in Winter Deaths
Seasonal influenza drives substantial excess mortality, yet its contribution is often obscured when infections go undiagnosed near the time of death. Many deaths occur outside hospitals or in older adults... Read moreCombined Screening Approach Identifies Early Leprosy Cases
Leprosy remains a significant public health concern, with more than 200,000 new cases reported globally each year and early disease often escaping routine laboratory detection. In its initial phase, bacterial... Read morePathology
view channelAI Improves Completeness of Complex Cancer Pathology Reports
Oncology teams increasingly rely on pathology reports that integrate histopathology, immunohistochemistry, and rapidly expanding biomarker testing. As patients live longer and undergo repeated analyses... Read more
AI Tool Predicts Chemotherapy Response in Small Cell Lung Cancer
Small cell lung cancer often presents at an extensive stage and progresses rapidly, leaving little time to tailor first-line therapy. Clinicians currently lack biomarkers to guide which patients will benefit... Read more
Tumor-Specific Biomarker Predicts Neoadjuvant Immunotherapy Response in Gastric Cancer
Gastric cancer is the fifth most common malignancy and the fourth leading cause of cancer mortality worldwide, with China bearing nearly half of the global burden. Only a subset of patients benefit from... Read moreTechnology
view channel
Noninvasive Sputum Test Detects Early Lung Cancer
Early detection remains critical for improving outcomes in lung cancer, yet clinicians increasingly encounter indeterminate pulmonary nodules found incidentally or through screening, complicating decision-making.... Read more
New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
Children with T-cell acute lymphoblastic leukemia face an aggressive disease that remains difficult to treat. Although remission rates have improved, many survivors experience long-term effects from intensive... Read more
Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection
Mass spectrometry is central to identifying and quantifying molecules in complex biological samples, but conventional instruments typically analyze ions sequentially, which can limit detection of rare species.... Read moreIndustry
view channel





.jpg)

